| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/08/2005 | CA2581703A1 Particulate comprising a calcium-containing compound and a sugar alcohol |
| 12/08/2005 | CA2568714A1 A biomolecule-containing formulation of increased stability |
| 12/08/2005 | CA2568542A1 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
| 12/08/2005 | CA2568378A1 Formulation obtained from a powder mixture comprising an inorganic pigment |
| 12/08/2005 | CA2568035A1 Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases |
| 12/08/2005 | CA2568007A1 Pharmaceutical compositions with enhanced performance |
| 12/08/2005 | CA2568006A1 Novel color cosmetic compositions |
| 12/08/2005 | CA2567963A1 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 12/08/2005 | CA2567961A1 Superloaded liposomes for drug delivery |
| 12/08/2005 | CA2567722A1 A dried and agglomerated hyaluronic acid product |
| 12/08/2005 | CA2567637A1 Using organic and/or inorganic potassium and its salts to treat autoimmune and other health disorders and methods of administering the same |
| 12/08/2005 | CA2567075A1 Pharmaceutical suspension composition |
| 12/08/2005 | CA2567056A1 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 12/08/2005 | CA2566798A1 Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| 12/08/2005 | CA2566311A1 Micropellet containing pellets and method of preparing such pellets |
| 12/08/2005 | CA2565886A1 Treatment of inflammatory airway disease |
| 12/08/2005 | CA2565545A1 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 12/08/2005 | CA2565098A1 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 12/08/2005 | CA2562565A1 Spot-on formulation useful for cosmetology and dermatology |
| 12/07/2005 | EP1602667A1 Aqueous formulation comprising TFPI and solubilising agents |
| 12/07/2005 | EP1602404A1 Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 12/07/2005 | EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use |
| 12/07/2005 | EP1602367A1 Transdermal delivery system for treatment of cognitive disorders |
| 12/07/2005 | EP1602366A1 Patch material for ionic medicine administration |
| 12/07/2005 | EP1602365A1 Pharmaceutical composition for topical use in form of xerogels or films and methods for production |
| 12/07/2005 | EP1602364A1 Microcapsules (XXX) comprising plant extracts and process for their preparation |
| 12/07/2005 | EP1602363A1 Immediate release dosage form comprising shell having openings therein |
| 12/07/2005 | EP1602362A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 12/07/2005 | EP1602361A2 Antibiotic in the form of a water-soluble powder for veterinary and human use |
| 12/07/2005 | EP1602360A1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 12/07/2005 | EP1602334A2 Apparatus for delivery of a therapeutic agent to aneurysmal tissue |
| 12/07/2005 | EP1601816A1 Dual electrode advanced electrochemical delivery system |
| 12/07/2005 | EP1601661A2 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| 12/07/2005 | EP1601408A2 Arrangement for remote-controlled release of active ingredients |
| 12/07/2005 | EP1601370A2 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 12/07/2005 | EP1601365A2 Prophylactic treatment of uv-induced epidermal neoplasia |
| 12/07/2005 | EP1601359A1 Liquid pharmaceutical formulations of palonosetron |
| 12/07/2005 | EP1601350A1 Titration dosing regimen for controlled release tramadol |
| 12/07/2005 | EP1601347A1 Use of a silica or silica derivative as a sorption material |
| 12/07/2005 | EP1601346A2 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method |
| 12/07/2005 | EP1601345A1 A controlled release system for pharmaceutical food and nutraceutical use |
| 12/07/2005 | EP1601344A2 Enhanced delivery of sphingolipids |
| 12/07/2005 | EP1601343A1 New process for the production of implants |
| 12/07/2005 | EP1601339A2 Skin peeling composition and method |
| 12/07/2005 | EP1601336A1 Aerosol dentifrice formulation |
| 12/07/2005 | EP1601326A2 Random alkylene oxide copolymers for medical and surgical utilities |
| 12/07/2005 | EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 12/07/2005 | EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 12/07/2005 | EP1439840B1 Monobactam antibacterial compounds and methods of use thereof |
| 12/07/2005 | EP1425381A4 Emu-based formulations for wound treatment related application information |
| 12/07/2005 | EP1337228B1 Compositions for removing human cerumen |
| 12/07/2005 | EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
| 12/07/2005 | EP1317439B1 Acid-sensitive compounds, preparation and uses thereof |
| 12/07/2005 | EP1294717B1 A thiazine oxazolidinone |
| 12/07/2005 | EP1272059B1 Method of producing oily suspensions of water-soluble vitamins |
| 12/07/2005 | EP1247529B1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs |
| 12/07/2005 | EP1220887B1 Protein-containing granules and granule formulations |
| 12/07/2005 | EP1196211B1 Enhanced thawing of biopharmaceutical solutions using oscillatory motion |
| 12/07/2005 | EP1178812B1 Methods of making conditioned cell culture medium compositions |
| 12/07/2005 | EP1165094B1 Dispersible macrolide compounds and method for the production thereof |
| 12/07/2005 | EP1161241B1 Stable pharmaceutical application form for paroxetin anhydrate |
| 12/07/2005 | EP1156831B1 Hydroxyethy starch for the painless and tissue-conserving injection of medicaments |
| 12/07/2005 | EP1156809B1 Mucin containing ophthalmic preparations |
| 12/07/2005 | EP1151751B1 Cataplasms containing vitamin c or its derivative |
| 12/07/2005 | EP1117412B1 Compositions containing diphosphonic acids |
| 12/07/2005 | EP1112060B1 Dosage form comprising liquid formulation |
| 12/07/2005 | EP1089727B1 Liposomal formulations of busulphan |
| 12/07/2005 | EP1079809B1 Enteric coated pharmaceutical composition and method of manufacturing |
| 12/07/2005 | EP1056477B1 Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins |
| 12/07/2005 | EP1052979B8 Device for releasing substances |
| 12/07/2005 | EP1024780B1 Reducing agent consisting of several components comprising at least one composition in form of a powder comprising a reducing agent for the disulfide bonds of hair and process for the permanent deformation of keratinic substances |
| 12/07/2005 | EP0998886B1 Hot fomentations |
| 12/07/2005 | EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 12/07/2005 | EP0738328B1 Composition containing nucleic acids, preparation and uses |
| 12/07/2005 | EP0730434B1 System for harmonic ultrasound imaging with microbubbles |
| 12/07/2005 | CN1705507A Method for the production of powdered active substance formulations by means of compressible fluids |
| 12/07/2005 | CN1705494A Colon cleansing compositions and methods |
| 12/07/2005 | CN1705482A Transdermal patch for external use comprising fentanyl |
| 12/07/2005 | CN1705472A Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 12/07/2005 | CN1705471A Deferacirox dispersible tablets |
| 12/07/2005 | CN1705470A Dosage form of sodium ibuprofen |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1704046A Liposome and its preparation process |
| 12/07/2005 | CN1704045A Supported suppository adapted for drug administering to cavity and its preparation method |
| 12/07/2005 | CN1230224C Osmotic beneficial agent delivery system |
| 12/07/2005 | CN1230206C Polymer blends as biodegradable matrices for preparing biocomposites |
| 12/07/2005 | CN1230203C Muco-adhesive polymers, use thereof and method for producing the same |
| 12/07/2005 | CN1230202C External coated chewing gum products |
| 12/07/2005 | CN1230200C Stable enzymatic wound debrider |
| 12/07/2005 | CN1230197C Y-IFN liquid-droplet aerosol and method |
| 12/07/2005 | CN1230196C Erythropoiesis for treating anemia of family and raised animals |
| 12/07/2005 | CN1230195C Oral preparation containing seaweed for reduction of plaque and calculus |
| 12/07/2005 | CN1230193C Water-purging pill |
| 12/07/2005 | CN1230188C Liquid preparation for external application for broad-spectrum sterilization and resisting herpes simplex virus |
| 12/07/2005 | CN1230184C Prepns. for immunotherapy for cancer having bacterial somatic constituent as active ingredient |
| 12/07/2005 | CN1230179C Micronized eplerenone compositions |
| 12/07/2005 | CN1230175C Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method |
| 12/07/2005 | CN1230167C Dual-release compositions of cyclooxygenase-2-inhibitor |
| 12/07/2005 | CN1230162C Pharmaceutical composition for modified release of an insulin sensitizing agent and another antidiabetic agent |
| 12/07/2005 | CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof |